Development and validation of serological markers for detecting recent Plasmodium vivax infection

A panel of serological exposure markers capable of classifying individuals with recent P. vivax infections who have a high likelihood of harboring hypnozoites are developed and can serve as a biomarker for identifying individuals who should be targeted with anti-hypnozoite therapy.